# AMLX (Amylyx Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Amylyx Pharmaceuticals, Inc. reported $0 in revenue and a net loss of $163.2M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/AMLX
- Markdown: https://convexityos.com/fundamentals/AMLX.md
- SEC CIK: 0001658551
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001658551&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$175.7M | Operating profit |
| Net Income | FY 2025 | -$163.2M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.37 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$123.5M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $768.1M | Total debt: $4.94M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $87.37M | $380.8M | $22.23M | $285K |
| Cost of Revenue | $0 | $5.95M | $25.44M | $2.99M | -- |
| **Gross Profit** | $0 | $81.42M | $355.3M | $19.24M | -- |
| Research & Development | $90.40M | $104.1M | $128.2M | $93.45M | $44.04M |
| Selling, General & Admin | $62.89M | $114.3M | $188.4M | $127.1M | $38.93M |
| **Operating Income** | -$153.3M | -$314.7M | $38.80M | -$201.3M | -$82.69M |
| **EBITDA** | -$152.8M | -$313.8M | $39.89M | -$200.9M | -$82.64M |
| Interest Income | $9.30M | $13.81M | $16.16M | $4.29M | $36K |
| Income Before Tax | -$144.7M | -$302.1M | $54.30M | -$197.6M | -$87.93M |
| Income Tax Expense | $46K | -$393K | $5.03M | $774K | -- |
| **Net Income** | -$144.7M | -$301.7M | $49.27M | -$198.4M | -$87.93M |
| Basic EPS | -$1.53 | -$4.43 | $0.73 | -$3.39 | -$13.35 |
| **Diluted EPS** | -$1.53 | -$4.43 | $0.70 | -$3.39 | -$13.35 |
| Basic Shares Outstanding | 94.6M | 68.1M | 67.2M | 58.5M | 6.6M |
| Diluted Shares Outstanding | 94.6M | 68.1M | 70.0M | 58.5M | 6.6M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $0 | $0 | -$665K |
| Cost of Revenue | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Gross Profit** | -- | -- | -- | $0 | $0 | $0 | $0 | -$665K |
| Research & Development | $28.35M | $23.77M | $27.61M | $21.21M | $19.86M | $27.22M | $22.12M | $22.89M |
| Selling, General & Admin | $21.31M | $21.93M | $16.17M | $15.39M | $16.17M | $15.64M | $15.68M | $17.10M |
| **Operating Income** | -$49.66M | -$45.69M | -$43.78M | -$36.60M | -$36.03M | -$42.86M | -$37.80M | -$40.65M |
| **EBITDA** | -$49.62M | -$45.65M | -$43.68M | -$36.50M | -$35.91M | -$42.72M | -$37.65M | -$40.49M |
| Interest Income | $4.18M | $2.32M | $2.57M | $3.29M | $1.82M | $1.96M | $2.23M | $2.32M |
| Income Before Tax | -- | -- | -- | -$32.95M | -$34.39M | -$41.44M | -$35.91M | -$38.18M |
| Income Tax Expense | -- | -- | -- | $46K | $0 | $0 | $0 | -$635K |
| **Net Income** | -$45.49M | -$43.42M | -$41.28M | -$33.00M | -$34.39M | -$41.44M | -$35.91M | -$37.55M |
| Basic EPS | -$0.38 | -$0.39 | -$0.37 | -- | -$0.37 | -$0.46 | -$0.42 | -- |
| **Diluted EPS** | -$0.38 | -$0.39 | -$0.37 | -- | -$0.37 | -$0.46 | -$0.42 | -- |
| Basic Shares Outstanding | 118.9M | 111.2M | 110.6M | -- | 93.3M | 89.1M | 85.7M | -- |
| Diluted Shares Outstanding | 118.9M | 111.2M | 110.6M | -- | 93.3M | 89.1M | 85.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $226.7M | $77.39M | $170.2M | $62.53M | $50.19M |
| Short-Term Investments | $90.33M | $99.11M | $201.2M | $284.4M | $45.93M |
| **Cash & Short-Term Investments** | $317.0M | $176.5M | $371.4M | $346.9M | $96.12M |
| Accounts Receivable, Net | $88K | $447K | $40.05M | $15.31M | -- |
| Inventory | -- | -- | $38.32M | $9.77M | -- |
| **Total Current Assets** | $323.7M | $189.4M | $464.7M | $382.1M | $105.0M |
| Property, Plant & Equipment, Net | $310K | $961K | $2.69M | $2.61M | $474K |
| Other Non-Current Assets | $2.50M | $24K | $701K | $466K | -- |
| **Total Non-Current Assets** | $8.97M | $4.20M | $52.79M | $9.32M | $663K |
| **Total Assets** | $332.6M | $193.6M | $517.5M | $391.5M | $105.6M |
| Accounts Payable | $3.52M | $2.94M | $22.06M | $6.26M | $4.37M |
| **Total Current Liabilities** | $22.69M | $28.41M | $82.04M | $46.61M | $17.40M |
| **Total Non-Current Liabilities** | $4.70M | $463K | $1.98M | $4.24M | $35K |
| **Total Liabilities** | $27.39M | $28.87M | $84.02M | $50.85M | $17.43M |
| **Total Debt (incl. Leases)** | $5.96M | $1.98M | $4.24M | $6.28M | -- |
| Common Stock | $11K | $7.0K | $7.0K | $7.0K | $1.0K |
| Retained Earnings | -$751.4M | -$606.7M | -$304.9M | -$354.2M | -$155.8M |
| Accumulated Other Comp. Income | $404K | -$92K | $197K | -$86K | $9.0K |
| **Total Stockholders' Equity** | $305.3M | $164.8M | $433.4M | $340.6M | -$151.2M |
| Total Equity | $305.3M | $164.8M | $433.4M | $340.6M | -$151.2M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $240.1M | $49.33M | $229.1M | $226.7M | $225.2M | $58.09M | $59.76M | $77.39M |
| Short-Term Investments | $528.0M | $201.4M | $50.63M | $90.33M | $118.8M | $122.7M | $144.3M | $99.11M |
| **Cash & Short-Term Investments** | $768.1M | $250.8M | $279.8M | $317.0M | $344.0M | $180.8M | $204.1M | $176.5M |
| Accounts Receivable, Net | -- | -- | -- | $88K | $132K | $103K | $300K | $447K |
| **Total Current Assets** | $778.9M | $256.3M | $285.0M | $323.7M | $353.4M | $186.9M | $216.1M | $189.4M |
| Property, Plant & Equipment, Net | $191K | $199K | $212K | $310K | $399K | $445K | $816K | $961K |
| Other Non-Current Assets | -- | -- | $2.50M | $2.50M | $2.50M | -- | $11K | $24K |
| **Total Non-Current Assets** | $7.94M | $8.23M | $8.58M | $8.97M | $9.36M | $7.71M | $3.53M | $4.20M |
| **Total Assets** | $786.8M | $264.6M | $293.6M | $332.6M | $362.7M | $194.6M | $219.7M | $193.6M |
| Accounts Payable | $4.80M | $5.53M | $3.53M | $3.52M | $5.34M | $3.29M | $4.81M | $2.94M |
| **Total Current Liabilities** | $29.05M | $21.15M | $15.97M | $22.69M | $25.79M | $21.42M | $17.93M | $28.41M |
| **Total Non-Current Liabilities** | $4.01M | $4.25M | $4.48M | $4.70M | $4.95M | $5.30M | $327K | $463K |
| **Total Liabilities** | $33.06M | $25.40M | $20.44M | $27.39M | $30.75M | $26.72M | $18.26M | $28.87M |
| **Total Debt (incl. Leases)** | $4.94M | $5.25M | $5.63M | $5.96M | $5.93M | $5.96M | $1.38M | $1.98M |
| Common Stock | $13K | $11K | $11K | $11K | $11K | $9.0K | $9.0K | $7.0K |
| Retained Earnings | -$881.6M | -$836.1M | -$792.7M | -$751.4M | -$718.4M | -$684.0M | -$642.6M | -$606.7M |
| Accumulated Other Comp. Income | -$179K | $19K | $240K | $404K | $815K | $551K | $0 | -$92K |
| **Total Stockholders' Equity** | $753.7M | $239.2M | $273.2M | $305.3M | $332.0M | $167.9M | $201.4M | $164.8M |
| Total Equity | $753.7M | $239.2M | $273.2M | $305.3M | $332.0M | $167.9M | $201.4M | $164.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$144.7M | -$301.7M | $49.27M | -$198.4M | -$87.93M |
| Depreciation & Amortization | $525K | $904K | $1.09M | $487K | $52K |
| Stock-Based Compensation | $27.64M | $33.04M | $37.16M | $21.71M | $3.14M |
| Change in Receivables | $359K | $39.60M | -$24.74M | -$15.31M | -- |
| Change in Inventory | -- | -$9.25M | -$73.13M | -$9.77M | -- |
| Change in Payables | $580K | -$19.10M | $15.88M | $1.85M | $670K |
| **Operating Cash Flow** | -$123.3M | -$167.6M | $11.92M | -$179.9M | -$74.80M |
| Capital Expenditure | -$138K | -$157K | -$1.24M | -$2.53M | -$353K |
| **Free Cash Flow** | -$123.5M | -$167.8M | $10.68M | -$182.4M | -$75.15M |
| Purchases of Investments | -$231.8M | -$232.0M | -$300.8M | -$415.9M | -$49.05M |
| **Investing Cash Flow** | $14.04M | $75.65M | $92.05M | -$239.0M | -$46.41M |
| **Financing Cash Flow** | $257.0M | $348K | $3.54M | $431.8M | $158.5M |
| **Net Change in Cash** | $148.8M | -$92.08M | $107.7M | $12.87M | $37.31M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$45.49M | -$43.42M | -$41.28M | -$33.00M | -$34.39M | -$41.44M | -$35.91M | -$37.55M |
| Depreciation & Amortization | $33K | $43K | $98K | $108K | $120K | $141K | $156K | $160K |
| Stock-Based Compensation | $10.37M | $8.32M | $6.12M | $6.39M | $7.08M | $7.35M | $6.83M | $6.74M |
| Change in Receivables | -- | -- | -- | $44K | -$30K | $198K | $147K | $1.28M |
| Change in Inventory | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Change in Payables | -$730K | $2.00M | $10K | $275K | -$33K | -$1.53M | $1.87M | $1.47M |
| **Operating Cash Flow** | -$33.67M | -$31.42M | -$36.88M | -$27.90M | -$30.37M | -$25.25M | -$39.82M | -$59.01M |
| Capital Expenditure | -- | -- | -- | -$86K | -$24K | -$17K | -$11K | -$20K |
| **Free Cash Flow** | -- | -- | -- | -$27.99M | -$30.39M | -$25.27M | -$39.84M | -$59.03M |
| Purchases of Investments | -- | -$180.8M | -$19.74M | -$30.45M | -$58.74M | -$38.99M | -$103.6M | $0 |
| **Investing Cash Flow** | -$325.7M | -$149.8M | $36.26M | $29.47M | $5.24M | $22.99M | -$43.66M | $64.98M |
| **Financing Cash Flow** | $550.2M | $1.48M | $3.22M | -$208K | $191.6M | -$31K | $65.66M | $110K |
| **Net Change in Cash** | $190.8M | -$179.8M | $2.49M | $1.48M | $166.6M | -$1.68M | -$17.62M | $5.56M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | 93.2% | 93.3% | 86.5% | -- |
| **Operating Margin** | -- | -360.2% | 10.2% | -905.7% | -29013.3% |
| **Net Profit Margin** | -- | -345.4% | 12.9% | -892.4% | -30853.0% |
| Return on Equity (ROE) | -47.4% | -183.1% | 11.4% | -58.2% | -- |
| Return on Assets (ROA) | -43.5% | -155.8% | 9.5% | -50.7% | -83.3% |
| Current Ratio | 14.27x | 6.67x | 5.66x | 8.20x | 6.03x |
| Quick Ratio | 13.98x | 6.23x | 5.20x | 7.99x | 5.53x |
| Debt to Equity | 0.02x | 0.01x | 0.01x | 0.02x | -- |
| **Revenue Growth (YoY)** | -100.0% | -77.1% | +1612.9% | +7700.0% | -- |
| Gross Profit Growth (YoY) | -100.0% | -77.1% | +1747.2% | -- | -- |
| Operating Income Growth (YoY) | -- | -911.1% | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -712.4% | -- | -- | -- |
| EPS Growth (YoY) | -- | -706.8% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -1506.6% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -1671.5% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | -- | 93.2% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -360.2% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -345.4% |
| Return on Equity (ROE) | -21.7% | -63.6% | -55.0% | -47.4% | -45.0% | -111.7% | -108.7% | -183.1% |
| Return on Assets (ROA) | -20.7% | -57.5% | -51.1% | -43.5% | -41.2% | -96.4% | -99.6% | -155.8% |
| Current Ratio | 26.81x | 12.12x | 17.85x | 14.27x | 13.70x | 8.72x | 12.05x | 6.67x |
| Quick Ratio | 26.44x | 11.86x | 17.52x | 13.98x | 13.34x | 8.45x | 11.40x | 6.23x |
| Debt to Equity | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.04x | 0.01x | 0.01x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -100.0% | -- | -100.0% | -100.6% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -100.0% | -- | -100.0% | -100.7% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -2202.1% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -893.6% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -535.5% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -547.4% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
